This IDC Market Perspective provides IDC Health Insights' review of key Q1 2019 IT deals, news, and digital initiatives in the European life sciences industry. In the evolving industry environment in Europe, it is critically important for life sciences companies to closely follow the fast-moving trends and developments to promptly spot favorable opportunities and remain competitive. This is the third in the quarterly series of reports IDC Health Insights has released following the expansion of its in-depth research coverage of life sciences markets across Europe.
"Investments continue to rise in digital solutions to enable drug traceability and supply chain transparency. The EU's FMD was enforced in February 2019, albeit with many companies still being far from full compliance. Similar regulations on drug serialization and traceability are evolving quickly outside the EU borders as well, and life sciences supply chain firms across Europe are actively looking for partners to help them in their journey to regulatory compliance. Meanwhile, collaborations with digital health start-ups continue to proliferate in a number of new areas, as companies strive to accelerate innovation across the entire life sciences value chain." — Senior Research Analyst Nino Giguashvili, IDC Health Insights Europe